News • Mechanopathology
'Dengue-on-a-chip' to study infection mechanisms
Due to the effects of climate change, dengue is spreading worldwide. Now, researchers have developed a 'dengue-on-a-chip' model that helps study the virus more effectively.
Search for: "virology" - 99 articles found
News • Study on antiviral therapy efficacy
Covid-19 treatment of immunocompromised patients: better late than never
Immunocompromised patients are at greatest risk of developing severe Covid-19 after an infection. While early antiviral treatments yield best results, even late-onset therapies still show benefits.
News • Antibiotic resistance control
Better tracking of AMR hospital bacteria
Infections caused by antibiotic-resistant (AMR) bacteria are a major issue in hospitals. A new technique aims to effectively track all types of relevant microorganisms simultaneously.
News • HAGIS project
German-Scottish teamwork against infectious diseases intensifies
Delegates from Hannover Medical School and the University of Glasgow have now signed a letter of intent to intensify their collaboration in the field of infection research.
Article • Knowledge gaps in gender medicine
Covid-19 and sex: higher mortality of male patients
The Covid-19 pandemic has affected scientific research in numerous ways – for example by highlighting knowledge gaps in gender medicine. In many studies differences in morbidity and mortality between women and men surfaced incidentally. While the extent and causes of these differences remain largely unexplored, the preliminary insights confirm the need for further research.
News • Environmental impact
Loss of biodiversity could benefit viral pathogens
Environmental changes may reduce the diversity of mosquitos, but bring about a greater abundance of viruses, scientists from Charité in Berlin in cooperation with Leibniz-IZW find.
News • Study on gentle cleansers
Virus-killing properties of soaps: No need for the 'hard stuff'
Gentle cleansers are just as effective in killing viruses – including coronavirus – as harsh soaps, according to a new study from scientists at the University of Sheffield.
News • New treatment insights
Successful cure of HIV infection after stem cell transplantation
A new study confirms that haematopoietic stem cell transplantation can be used to cure patients with HIV infections. This third successful case gives new insights into the underlying processes.
News • "COMPASS" method
Using nanoparticles for more sensitive rapid tests
A newly developed rapid test needs only a few seconds to reliably detect pathogens such as SARS-CoV-2. It is based on specially designed magnetic nanoparticles.
News • 'Synthetic origin' theory of SARS-CoV-2 debunked
Was the coronavirus engineered in a lab? Experts cast doubt on new analysis
Research presented in a new preprint suggests that SARS-CoV-2 might have been artificially created in a laboratory. Experts from Würzburg have reviewed the paper – and remain unconvinced.
News • Conference attendance
New lab systems for virology showcased at ESCV 2022
Dutch global DNA/RNA technology solutions provider MolGen B.V., participates in the 24th Annual Conference of the European Society for Clinical Virology (ESCV) held in Manchester, UK.
Sponsored • Handheld diagnostics
Veros™ COVID-19 test now available in Europe
Handheld, instrument-free test delivers lab-quality molecular results – 97.9% accuracy – in about 15 minutes, right at the point of care.
News • To enter human cells
SARS-CoV-2 hijacks antiviral human proteins
SARS-CoV-2 depends on the broadly antiviral interferon-induced human transmembrane proteins , to enter human cells and replicate inside them.
News • Mini-livers on a chip
Organoids: step towards hepatitis C vaccine
A platform for studying how the human immune system responds to hepatitis C infection by combining microfluidic technology with liver organoids could speed the hunt for a vaccine.
News • COVID and E. coli
Futuristic coating for fabrics kills viruses
Researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.
News • Hard to break down
Hepatitis E: Most common hand infectants no match for HEV
Scientists have investigated the effectiveness of various common hand disinfectants against hepatitis E. They were able to show that most formulations do not completely inactivate the virus.
News • Viral subtypes
Coronavirus evolution: 'Even Omicron has three variants'
Professor Richard Neher from the Biozentrum of the University of Basel is using his Nextstrain platform to investigate which variants of the SARS-CoV-2 virus are currently circulating worldwide.
News • Coronavirus research
Why the Omicron variant causes less severe disease
A new study shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defence mechanism against viruses, the so-called 'interferon response'.
News • Sensitivity and response detection
How long do tests detect SARS-CoV-2 antibodies? New insights
How long can Covid-19 antigen tests reliably tell the antibody status? Researchers at the Paul-Ehrlich-Institut identified several factors that affect the detection duration.
News • UV-C barrier against aerosols
An 'invisible wall' to keep out SARS-CoV-2
An invisible protective wall of UV-C light developed by researchers in Munich could reliably curb the spread of viruses and other pathogens in rooms while allowing total freedom of movement.
Article • New EU regulation
Lab tests: Watch out! Conflict ahead
In May 2022 a shortage of several lab tests may come as many manufacturers struggle to comply with EU regulation requirements covering in vitro diagnostic medical devices (IVDR, Regulation (EU) 2017/746). Even modified tests and laboratory-developed tests will present a problem for hospitals and labs as explained by Dr Thomas Streichert.
News • Coronavirus inhibition
Highly potent antibody against SARS-CoV-2 discovered
Scientists at Lausanne University Hospital (CHUV) and École polytechnique fédérale de Lausanne (EPFL) have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified to date, including the delta variant. Their findings are published in the journal Cell Reports.
Sponsored • Demand for molecular LIMS increases
Lab interoperability is essential
Fast, flexible laboratory information management systems (LIMS) that cope with data and workflow complexities of molecular and genetic testing now work in laboratories internationally. Here, in the first in a new Lab Pinnacle Series, experts from the CliniSys Group, Sunquest Information Systems and Data Innovations (all owned by Roper Technologies), discuss the value of a LIMS in molecular and…
News • Autoimmune reaction study
Severe Covid-19 linked to increase in self-attacking antibodies
Hospitalized Covid-19 patients are substantially more likely to harbor autoantibodies — antibodies directed at their own tissues or at substances their immune cells secrete into the blood — than people without Covid-19, according to a new study.
News • Coronavirus research
Contagious cash? The role of banknotes and coins in Covid-19 infections
How long do coronaviruses remain infectious on banknotes and coins? Is it possible to become infected through contact with cash? Experts at the European Central Bank, in collaboration with the Department of Medical and Molecular Virology at Ruhr-Universität Bochum, wanted to clarify this question. The researchers led by Professor Eike Steinmann and Dr. Daniel Todt developed a method specifically…
News • Covid-19 detection
New blood test measures immunity against SARS-CoV-2 and its variants
The Lausanne University Hospital (CHUV) and EPFL teamed up to develop a new test that’s sensitive enough to measure the amount of SARS-CoV-2 neutralizing antibodies present in the bloodstream. The scientists’ discovery, published in Science Translational Medicine, opens promising new avenues for tracking immunity acquired by infection or vaccination.
News • Mechanical inactivation
'Nano traps' to lock up and neutralize viruses
To date, there are no effective antidotes against most virus infections. An interdisciplinary research team at the Technical University of Munich (TUM) has now developed a new approach: they engulf and neutralize viruses with nano-capsules tailored from genetic material using the DNA origami method. The strategy has already been tested against hepatitis and adeno-associated viruses in cell…
News • Unexpected find
Anti-tapeworm drug shows promise against Covid-19
Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism of the host cell in order to gain an overall advantage. According to their report in Nature Communications, the researchers were able to identify four substances which inhibit SARS-CoV-2…
News • After overcoming a Corona infection
Covid-19: Study on long-term antibody protection
Does overcoming a SARS-CoV-2 infection protect against reinfection? The “Rhineland Study”, a population-based study conducted by DZNE in the Bonn area, is now providing new findings in this regard. Blood samples taken last year indicate that an important component of immunity – the levels of specific neutralizing antibodies against the coronavirus - had dropped in most of the study…
News • SARS-CoV-2 vs the proteome
Researchers explore coronavirus interactions with cells
Scientists from Würzburg and the US have charted the first global atlas of direct interactions between SARS-CoV-2 RNA and human host cells. This may provide a starting point for novel treatments. SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the…
Article • Preventing endoscope contamination
Ways to enhance hygiene in endoscopy
Stringent endoscope cleaning between procedures is vital. However, with so many steps in the process – plus high demand for rapid turnaround of endoscopes – contamination and biofilm build-up are still being reported. Endoscope hygiene and cleaning protocols were central to an online event organised by Pentax Medical, with important contributions from leading specialists. The event examined…
News • COVID-19
CRISPR test uses smartphone to detect SARS-CoV-2
Scientists at UC Berkeley and Gladstone Institutes have developed a new CRISPR-based COVID-19 diagnostic test that, with the help of a smartphone camera, can provide a positive or negative result in 15 to 30 minutes.
News • Electron microscopy
Replication cycle of SARS-CoV-2 in 3D
In a new study, researchers performed a detailed imaging analysis to determine how the virus reprograms infected cells.
Article • Diagnosing SARS-CoV-2
The arsenal: Molecular (PCR), antigen and antibody testing
Germany’s lack of diagnostic ability led to significantly underestimation of its own as well as global Covid-19 infection levels during the first wave. Now, however, improved testing and diagnosis of the condition more realistically reveal nearer 20,000 new cases a day across the country, according to Professor Hendrik Streeck, one of the country’s leading virologists. Speaking at a virtual…
Article • Virology
Digital epidemiology in the Covid-19 war
Digital epidemiology is on the frontline in the Covid-19 war, with innovative techniques used to observe and monitor this viral spread across populations. Its increasingly important role was outlined to a virtual session at Medica 2020 by theoretical biologist Professor Dirk Brockmann. In a keynote presentation ‘Perspective of digital epidemiology – opportunities, promises and challenges’,…
Video • New insights on the virus' ‘survivability’
How long does SARS-CoV-2 last on surfaces?
Researchers at CSIRO, Australia's national science agency, have found that SARS-CoV-2, the virus responsible for COVID-19, can survive for up to 28 days on common surfaces including banknotes, glass – such as that found on mobile phone screens - and stainless steel.
Article • Covid-19 disinfection
New insights into SARS-CoV-2 surface stability and temperature susceptibility
Surface disinfection has proved an effective method to control Covid-19 infection, as virologists from the Ruhr University Bochum (RUB) have shown. However, an effective disinfection strategy against Coronavirus must consider various factors, says Professor Eike Steinmann, head of the Department of Molecular and Medical Virology at the RUB.
News • Coronavirus
Lab-made virus mimics COVID-19 virus
Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions. Scientists handling the infectious virus must wear full-body biohazard suits with pressurized respirators, and work inside laboratories with multiple containment levels and specialized ventilation systems. While necessary to protect laboratory workers, these safety…
News • Airborne droplet travel distance
Why you shouldn't underestimate the reach of COVID-19
A plea issued by 239 scientists from around the world to recognise and mitigate airborne transmission of COVID-19 addressed to international health authorities is published in the journal Clinical Infectious Diseases. Led by internationally recognised air quality and health expert Professor Lidia Morawska from Queensland University of Technology (QUT), the appeal is to address the overwhelming…
News • Light or severe progression
The dangerous dual role of the immune system in COVID-19
Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course: some of those infected do not even notice it, while others become so seriously ill that their lives are placed at risk. Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin and their colleagues from Leipzig and Heidelberg have now discovered that the immune system has a…
News • Fluoxetine
Antidepressant inhibits coronavirus
A standard drug for the treatment of depression might also be effective against Covid-19, a new study by Würzburg scientists shows which has been published on a preprint server
News • Changes in cells caused by coronavirus
Potential targets for COVID-19 therapy discovered
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people. The scientists tested a series of compounds in laboratory models and found some which slowed down or stopped virus reproduction. These results now enable the search for an active substance…
Video • Going viral
Coronavirus clone produced in the lab
Researchers in virology and veterinary bacteriology at the University of Bern have cloned the novel coronavirus (SARS-CoV-2). The synthetic clones are being used by research groups worldwide to test corona samples, find antiviral drugs and develop vaccines as quickly as possible. The method developed in Bern can also be used in future to combat other highly infectious viruses. In the…
Article • Paradigm shift for point-of-Care-Testing
IT security of POCT devices – not everything is picture-perfect
Until recently, the major challenges surrounding Point-of-Care-testing (POCT) concerned the quality of the results and improving the reagents and the procedures in order to optimise patient care. In the modern clinical environment, however, IT security of POCT devices is becoming increasingly important, in Germany also due to new industry-specific safety standards under the Act on the Federal…
Article • Breath analysis to aid diagnoses
Breathomics: far more than hot air
In diagnostics, it sometimes makes sense to follow your nose. During the Labmed Forum at Medica, Dr Beniam Ghebremedhin and Dr Simona Cristescu discussed the diagnostic potential of breathomics – the analysis of a patient’s exhaled air for disease indicators.
Article • Radiographers in Spain report
Equipment hygiene: taking back center stage during the COVID-19 pandemic
The COVID-19 pandemic is putting extra pressure on radiology services. Radiographers are particularly at risk of catching and spreading the disease. This is why they must follow strict cleaning and disinfection protocols, according to Pablo Valdés Solís, President of the Spanish Society of Radiology (SERAM), who has just published new guidelines on how to protect staff and patients, as the…
News • COVID-19 diagnostics
Corona 'pool testing' increases worldwide capacities many times over
Researchers at the German Red Cross Blood Donor Service in Frankfurt headed by Professor Erhard Seifried, and the Institute for Medical Virology at the University Hospital Frankfurt at Goethe University headed by Professor Sandra Ciesek succeeded in developing a procedure that makes it possible to immediately and dramatically increase worldwide testing capacities for detecting SARS-CoV-2.
News • COVID-19 longevity
How long can the coronavirus persist on surfaces?
How long can coronavirus persist on surfaces such as door handles or hospital nightstands? How can the virus be destroyed effectively? A research team from Greifswald and Bochum, Germany, collected the answers scientists can currently offer to these and other pertinent questions and published them in the Journal of Hospital Infection.
News • Pandemic prevention
German lab developed coronavirus detection method
Investigators at Hannover Medical School (MHH) in Germany have developed a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on the automated Panther Fusion system by Hologic. The preclinical assay is described online in the Journal of Clinical Virology. “Rapid diagnosis is critical to combatting the spread of pandemics, and the Panther Fusion system is well…
News • Genomic insights into 2019-nCoV
New coronavirus: largest meta-analysis yet answers important questions
Scientists at the University of Bologna have conducted the largest analysis of coronavirus 2019-nCoV genomes sequenced so far. This analysis confirms that the virus originates in bats and shows a low variability: the virus heterogeneity is low. At the same time, researchers identified a hyper-variable genomic hotspot in the proteins of the virus responsible for the existence of two virus…
Article • Significant improvement in cleaning, disinfection and sterilisation
Surgical robots must also be hygienic
Modern healthcare without hand hygiene? Inconceivable – particularly in the operating room (OR). But what happens when it is not the surgeon who handles the scalpel, but a robot? Robotic surgery, just like surgery performed by humans, always carries a risk of microbial transmission to the patient, says Professor Johannes K-M Knobloch of University Hospital Hamburg-Eppendorf (UKE). A specialist…
Article • Positive findings in PD-1 inhibitor immunotherapy
Hope increases for HIV cancer patients
Advances in antiretroviral therapy mean that today, people infected with the human immunodeficiency virus (HIV) can expect a healthy and long life. However, living with HIV does increase the risk of cancer. The reasons for this are multiple and include behavioural risk factors (smoking etc.) but many cancers can be attributed to the effects the virus has on the immune system, specifically its…
News • Promising preclinical study results
Epilepsy: Gene therapy shows long-term suppression of seizures
Teams of researchers from Charité – Universitätsmedizin Berlin and the Medical University of Innsbruck have developed a new therapeutic concept for the treatment of temporal lobe epilepsy. It represents a gene therapy capable of suppressing seizures at their site of origin on demand. Having been shown to be effective in an animal model, the new method will now be optimized for clinical use.…
Article • MERS-CoV
Seeking answers to combat Middle East respiratory syndrome
With a case fatality rate of 35 percent, a Middle East respiratory syndrome-related coronavirus (MERS-CoV) infection – also called camel flu – is a dangerous disease. About seven years ago, when the virus was first isolated, mortality was close to 100 percent since only severe infections that led to the patient being in intensive care were recorded. Today the environment of each victim is…
News • CRISPR-fied chickens
Gene-edited chicken cells could leave flu with nowhere to hide
Scientists from Imperial College London and the University of Edinburgh have used gene-editing techniques to stop the bird flu virus from spreading, in chicken cells grown in the lab.
Article • Differentiate and select
Myths and truths about antibiotics, antiseptics and vaccination
Sixty-two percent of Germans fear antibiotic resistance, according to a survey recently conducted by the German Federal Institute for Risk Assessment. ‘Patients colonised by multi-resistant pathogens are particularly scared. But many of these fears are rooted in misunderstandings,’ explained Professor Mathias Pletz at the Congress for Infectious Diseases and Tropical Medicine (KIT).
News • Virology
Trapping viruses inside a cell: harmful or helpful?
Viruses are often used as vehicles for delivery in gene therapy because they’re engineered not to damage the cell once they get there, but neglecting to consider how the virus will exit the cell could have consequences. Some viruses use a molecule called heparan sulfate to help them attach to cells. The molecule, found in many different kinds of cells (including those from animal tissue), could…
Article • Interdisciplinary
Exploring the human microbiome
During the International Forum for Laboratory Medicine, one seminar focused on infectious diseases. Professor André Gessner, from the Medical Microbiology and Hygiene Department at Regensburg University, lectured on ‘The human microbiome, an explosive ‘climate’ topic,’ he explained.
News • Bordetella
Launch of Hologic's whooping cough detection assay in Europe
Hologic, Inc. announced that its Panther Fusion Bordetella assay has received CE mark in Europe. This assay, the latest in a growing menu of Panther Fusion and Aptima assays, brings full automation, efficiency and excellent assay performance to Bordetella (whooping cough) detection. The Panther Fusion system retains all the key benefits of the Panther platform, including full sample-to-result…
News • Therapy
Could these special antibodies lead to HIV vaccine?
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the University of Zurich and the University Hospital Zurich have now shown that the genome of the HI virus is a decisive factor in determining which antibodies are formed.
News • Research
Zika virus proteins inhibit brain development
In healthy individuals, the Zika virus causes flu-like symptoms. If a pregnant woman becomes infected, the unborn child can suffer from severe brain abnormalities as a result of mechanisms that have not yet been explained. A study by the Technical University of Munich (TUM) and the Max Planck Institute of Biochemistry (MPI-B) shows that Zika virus proteins bind to cellular proteins that are…
News • Experts discuss
Digital health – help or hype? A bit of both, probably
ISPOR, the professional society for health economics and outcomes research, held its second plenary session, “Digital Health—Help or Hype?,” this morning at ISPOR 2018 in Baltimore, MD, USA. As digital technologies such as smart phones, social media, and wearables have increasingly become available, the potential opportunities for tracking health metrics and enhancing participation in…
News • Dual-use technology
From healthcare to warfare: How to regulate brain technology
Ethicists from the University of Basel have outlined a new biosecurity framework specific to neurotechnology. While the researchers declare an outright ban of dual-use technology ethically unjustified, they call for regulations aimed at protecting the mental privacy and integrity of humans. The journal Neuron has published the study. The term “dual-use” refers to technology that can be used…
News • Study
Secrets of Ebola uncovered - in the heart of a devastating outbreak
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts. Conducting a sweeping analysis of everything from enzymes to lipids to immune-system-associated molecules,…
Interview • Multiresistant pathogens
'Antibiotics don’t generate large profits'
During our European Hospital interview with specialist in microbiology, virology and infection epidemiology Beniam Ghebremedhin MD, from the University Hospital Wuppertal, spoke about the impact of migration on infections, and ways to tackle the problem of multiresistant pathogens. ‘There is a lack of specialists in infectious diseases, for direct patient care on hospital wards as well as in…
Interview • From step-child to limelight
Virologists: Interdisciplinary and global cooperation is vital
Over recent years, virology, once medicine‘s step-child, moved into the limelight, pushed by impressive progress and pulled by globalisation-induced need for expertise in virus diagnostics and viral epidemics.
Article • Diagnosing Zika
Commercial blood test proves reliable
The Society for Virology (GfV) which promotes virology through the increase and exchange of research within German speaking countries, as well as via cooperation with other scientific societies, announced this year that a new test can unambiguously confirm the diagnosis of a Zika virus infection – leading to fast diagnosis and identification of an infection.
News • Virus study
Close contact not at fault for Zika spread
Saliva is no way to pass a Zika virus infection. According to researchers at the University of Wisconsin–Madison who conducted studies with monkeys, casual contact like kissing or sharing a fork or spoon is not enough for the virus to move between hosts.
Article • Infection control
Global warming: Science can only react to emerging diseases
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ program for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years. Therefore, key congress topics included the Zika virus, the effects of global warming and the unusually high number of hospital-acquired…
Interview • Infection control
Virologists are today’s universal necessities
Globalisation has been a defining term in this 21st century: with almost anybody able to visit any place at any time, diseases, viruses and bacteria can be travel companions. Thus virology is gaining increased attention. Professor Barbara Gärtner, President of the German Association of Virology, talks about the issues and challenges arising from this development.
Article • Infections
Science can only react
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ programme for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years.
Article • Molecular diagnostics
A one-step system for faster turnaround of hospital samples
A new molecular diagnostics system is revolutionising analysis of hospital samples across an area of northern Italy. The Greater Romagna Area Hub Laboratory has recently installed the Beckman Coulter DxN VERIS Molecular Diagnostics System and is already reporting improved workflow and quicker turnaround time for results.
Interview • Zika infections subside
‘I would travel to South America any time,’ virologist confirms
In Europe, the first baby with Zika-related microcephaly was born in July. The mother had contracted the Zika virus while travelling in America. How dangerous is the virus for Europeans, particularly since many visited Brazil for the Olympic Games in Rio?
Article • Frontline medical advances
Virology is now a key discipline
Virology is fast emerging as a key discipline within modern healthcare against a backdrop of a shifting global demographic and the impact of climate change.
News • dormant viruses
Researchers Find Herpes Strain in the Nervous System
There are a couple strains of herpes so common that researchers estimate 90% of the human population have them. These strains, human herpes 6 and human herpes 7, usually do not cause severe symptoms when people acquire them. But researchers know that under certain circumstances, dormant herpes viruses in the body can unexpectedly come roaring back and cause complications not typically associated…
News • Virology
Tricks of ticking time bomb Hepatitis B virus
Hepatitis B virus (HBV) causes hepatitis B, an infectious disease that afflicts 230 million people worldwide, thereof 440 000 in Germany. Persistence of the virus in liver cells leads to progressive organ damage in the patient and contributes to a high risk of cirrhosis and liver cancer development. Providing a new paradigm to hepatitis B understanding, researchers at the German Cancer Research…
News • Research
Zika: Experimental drug slows down infection
Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.
News • Rio de Janiero
First description of 2015 Zika virus outbreak
Since the recent link to severe neurological defects in infants born to mothers infected during pregnancy, Zika virus (ZIKV) has become a public health and research priority. A study reports details from the 2015 Zika outbreak in Rio de Janeiro - the first with a high proportion of cases confirmed by molecular diagnosis - and proposes changes to the current diagnostic criteria for ZIKV disease.
News • Noroviruses
Lemon juice and human norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center. Therefore, lemon juice could be a potentially safe and practical disinfectant against the most common pathogen of severe gastrointestinal infections.
Article • Human resources
A pathology workforce fit for the future
The UK pathology sector faces numerous challenges as it strives to create a future medical laboratory workforce. As in many divisions of the National Health Service (NHS), this area has an ageing population yet must evolve against a backdrop of fast-developing technologies, emerging science, financial constraints and the challenge of working in tandem with the private sector. Report: Mark…
Article • testing Ebola
New mobile lab case sees action in Guinea
Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The new procedure is six to ten times faster than the one currently used, and equally sensitive. Report: Anja Behringer
Article • Automation
Reducing laborious microbiology testing
Automation of high-volume biochemistry and immunology laboratories has been on-going for more than a decade, yet central laboratories only recently dared to take on the daunting task of automating the more complex processes of microbiology. Report: John Brosky
Article • Study
Jet air and warm air driers unsuitable for use in healthcare settings
A new study concludes that jet air and warm air hand driers have a greater potential to contaminate washrooms by spreading bacteria into the air and onto users and bystanders. The findings have significant implications for infection control health professionals and purchasing managers responsible for equipping hospital washrooms.
Deadly virus seemingly unstoppable
Fever, vomiting, internal and external bleeding – these are the symptoms of the Ebola virus infection. The current epidemic in Guinea, Liberia and Sierra Leone is the largest recorded Ebola outbreak ever and a serious challenge for the healthcare institutions worldwide.
MERS-CoV: Global action needed?
The World Health Organisation (WHO) recently formed an international emergency committee to decide whether Middle East Respiratory Syndrome Coronavirus (MERS-CoV) should be ascribed Public Health Emergency of International Concern (PHEIC) status, amid reports of a lack of information from the worst affected countries.
Faster sample analysis for UK and EU hospitals
Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.
Quality control via round robin tests
If a parameter is determined with different test systems the results must still be comparable. This sounds simple, but is hard to achieve.
Strategic lab control
Managing physicians’ test requests is a key ingredient of modern lab management. However, doctors and nurses still do not provide the clinical reasons for orders to all labs.
Investigating the HFN1 virus
Dutch virologist Ron Fouchier and his colleagues around the world stopped their research into the bird flu virus H5N1 for a whole year to allow an international debate surrounding the benefits and risks of their work.
Study unravels the hidden genomic complexity of the giant mimivirus
A study published online today in the journal Genome Research offers surprising new clues into the genomic complexity of the giant Mimivirus, the largest known virus in the world. Previous studies have shown that unlike most viruses, the Mimivirus has more genes than many bacteria and performs functions that normally occur only in cellular organisms. The results of the most recent study, led by a…
40 years of MEDICA
When we organised the first Diagnostic Week in Karlsruhe, in 1969, no one could have known that this event would one day turn into the annual highlight in the world of medicine, reflected Dr Wolfgang Albath, laboratory medicine pioneer and one of the founding fathers of MEDICA the world`s largest medical trade show. Initially planned as a moving exhibition, the show has been based in…
Futures: HIV self-monitoring
HIV/AIDS has reached pandemic proportions. 35 million people are infected. Given the situation of hard pressed general practitioners (GPs) today, as well as geographical and other difficulties (as in Africa, for example), a new device that will enable HIV patients to monitor their own health and the effectiveness of treatments, without visiting their doctors so often, is indeed promising.
New treatment guidelines for HIV infection
An international panel of physicians has updated the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection after evaluating recent data, according to an article in JAMA, a theme issue on HIV/AIDS.
The modern laboratory information and management system
Germany - Managing a lab for out- and in-patient care involves not only mastering increasing pressures in terms of efficiency and cost-optimisation, but also being au courant with ever evolving clinical issues and state-of-the-art lab technology and procedures.
"First Lady" named at the ETH Zurich
It took 152 years, but now the ETH (Eidgenössische Technische Hochschule) Zürich for the first time named a femal rector: Prof. Heidi Wunderli-Allenspach. She will succeed the present Rector, Prof. Konrad Osterwalder in September and will join the club of European rectors that has really been a men´s world so far.
Seeking life's chemical processes
Since the human genome was mapped 'systems biology' centres have sprung up all over Europe, including Bioquant in Heidelberg, Germany.
Verdict 'soon' in Libya
The five Bulgarian nurses and a Palestinian doctor, accused of intentional mass HIV infection, face their final court sitting on 31 October. A verdict is expected soon afterwards.
Todays treatments
Dr Christiane Eickelberg, of the University of Giessen Lung Centre (UGLC), outlines the centre's research projects, aims and academic offerings
HIV
Medication regimes based on cocktails of antiretroviral drugs can reduce the AIDS virus to almost undetectable levels.